OPTN

optineurin

Basic information

Region (hg38): 10:13099449-13138308

Previous symbols: [ "GLC1E" ]

Links

ENSG00000123240NCBI:10133OMIM:602432HGNC:17142Uniprot:Q96CV9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • amyotrophic lateral sclerosis type 12 (Strong), mode of inheritance: AR
  • amyotrophic lateral sclerosis type 12 (Strong), mode of inheritance: Semidominant
  • glaucoma 1, open angle, E (Limited), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 12 (Strong), mode of inheritance: AR
  • amyotrophic lateral sclerosis (Supportive), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 12 (Strong), mode of inheritance: AR
  • amyotrophic lateral sclerosis type 12 (Strong), mode of inheritance: AD
  • glaucoma 1, open angle, E (Strong), mode of inheritance: AD
  • amyotrophic lateral sclerosis type 12 (Definitive), mode of inheritance: Semidominant
  • glaucoma, normal tension, susceptibility to (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Glaucoma, normal tension, susceptibility to; Glaucoma primary open angleADOphthalmologic; PharmacogenomicOpen-angle glaucoma is typically asymptomatic until late stages, when irreversible nerve damage has already taken place; Agents that may contribute to glaucoma should be avoidedNeurologic; Ophthalmologic11834836; 17389490; 20428114; 21613650; 21644038; 21730848; 22708870; 22402017; 23062601; 21852022; 21802176

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the OPTN gene.

  • Amyotrophic_lateral_sclerosis_type_12 (335 variants)
  • Primary_open_angle_glaucoma (328 variants)
  • Glaucoma_1,_open_angle,_E (316 variants)
  • not_provided (114 variants)
  • Inborn_genetic_diseases (92 variants)
  • OPTN-related_disorder (62 variants)
  • not_specified (15 variants)
  • Motor_neuron_disease (4 variants)
  • Amyotrophic_lateral_sclerosis (3 variants)
  • Amyotrophic_Lateral_Sclerosis,_Recessive (2 variants)
  • Frontotemporal_dementia (1 variants)
  • Glaucoma,_normal_tension,_susceptibility_to (1 variants)
  • Amyotrophic_lateral_sclerosis_type_10 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the OPTN gene is commonly pathogenic or not. These statistics are base on transcript: NM_001008212.2. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
5
clinvar
74
clinvar
1
clinvar
80
missense
2
clinvar
5
clinvar
201
clinvar
7
clinvar
3
clinvar
218
nonsense
10
clinvar
8
clinvar
2
clinvar
20
start loss
1
1
frameshift
14
clinvar
15
clinvar
2
clinvar
31
splice donor/acceptor (+/-2bp)
3
clinvar
9
clinvar
1
clinvar
13
Total 29 37 212 81 4

Highest pathogenic variant AF is 0.0000706358

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
OPTNprotein_codingprotein_codingENST00000378748 1338843
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
5.91e-180.013012560321431257480.000577
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6222672970.8980.00001563833
Missense in Polyphen6478.6080.814171090
Synonymous-0.6011231151.070.000006471038
Loss of Function0.4282830.60.9160.00000140395

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0008500.000850
Ashkenazi Jewish0.003670.00368
East Asian0.00005460.0000544
Finnish0.00009250.0000924
European (Non-Finnish)0.0006250.000580
Middle Eastern0.00005460.0000544
South Asian0.0001310.000131
Other0.001630.00147

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays an important role in the maintenance of the Golgi complex, in membrane trafficking, in exocytosis, through its interaction with myosin VI and Rab8 (PubMed:27534431). Links myosin VI to the Golgi complex and plays an important role in Golgi ribbon formation (PubMed:27534431). Plays a role in the activation of innate immune response during viral infection. Mechanistically, recruits TBK1 at the Golgi apparatus, promoting its trans-phosphorylation after RLR or TLR3 stimulation (PubMed:27538435). In turn, activated TBK1 phosphorylates its downstream partner IRF3 to produce IFN-beta. Plays a neuroprotective role in the eye and optic nerve. May act by regulating membrane trafficking and cellular morphogenesis via a complex that contains Rab8 and hungtingtin (HD). Mediates the interaction of Rab8 with the probable GTPase-activating protein TBC1D17 during Rab8-mediated endocytic trafficking, such as of transferrin receptor (TFRC/TfR); regulates Rab8 recruitment to tubules emanating from the endocytic recycling compartment. Autophagy receptor that interacts directly with both the cargo to become degraded and an autophagy modifier of the MAP1 LC3 family; targets ubiquitin-coated bacteria (xenophagy), such as cytoplasmic Salmonella enterica, and appears to function in the same pathway as SQSTM1 and CALCOCO2/NDP52. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:15837803, ECO:0000269|PubMed:20085643, ECO:0000269|PubMed:20174559, ECO:0000269|PubMed:21617041, ECO:0000269|PubMed:22854040, ECO:0000269|PubMed:27534431, ECO:0000269|PubMed:27538435}.;
Disease
DISEASE: Glaucoma 1, open angle, E (GLC1E) [MIM:137760]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:11834836, ECO:0000269|PubMed:12939304, ECO:0000269|PubMed:14597044, ECO:0000269|PubMed:15226658, ECO:0000269|PubMed:15326130, ECO:0000269|PubMed:15557444, ECO:0000269|PubMed:17389490, ECO:0000269|PubMed:20085643, ECO:0000269|PubMed:22854040, ECO:0000269|PubMed:23669351, ECO:0000269|PubMed:24752605}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Glaucoma, normal pressure (NPG) [MIM:606657]: A primary glaucoma characterized by intraocular pression consistently within the statistically normal population range. {ECO:0000269|PubMed:15370540}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Amyotrophic lateral sclerosis 12 (ALS12) [MIM:613435]: A neurodegenerative disorder affecting upper motor neurons in the brain and lower motor neurons in the brain stem and spinal cord, resulting in fatal paralysis. Sensory abnormalities are absent. The pathologic hallmarks of the disease include pallor of the corticospinal tract due to loss of motor neurons, presence of ubiquitin-positive inclusions within surviving motor neurons, and deposition of pathologic aggregates. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5- 10% of the cases. {ECO:0000269|PubMed:20428114, ECO:0000269|PubMed:27534431}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Mitophagy - animal - Homo sapiens (human);Vesicle-mediated transport;TBC/RABGAPs;Membrane Trafficking;Regulation of PLK1 Activity at G2/M Transition;Rab regulation of trafficking;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;Cell Cycle, Mitotic;Optineurin and Myosin Phosphatase Negatively Regulate PLK1 (Consensus)

Recessive Scores

pRec
0.220

Intolerance Scores

loftool
0.0731
rvis_EVS
-0.58
rvis_percentile_EVS
18.72

Haploinsufficiency Scores

pHI
0.128
hipred
Y
hipred_score
0.515
ghis
0.568

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.978

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Optn
Phenotype
homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Zebrafish Information Network

Gene name
optn
Affected structure
neuron
Phenotype tag
abnormal
Phenotype quality
decreased speed

Gene ontology

Biological process
G2/M transition of mitotic cell cycle;negative regulation of receptor recycling;autophagy;Golgi organization;signal transduction;cell death;positive regulation of autophagy;protein localization to Golgi apparatus;cellular response to unfolded protein;Golgi to plasma membrane protein transport;negative regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response;defense response to Gram-negative bacterium;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;Golgi ribbon formation;positive regulation of xenophagy
Cellular component
Golgi membrane;nucleus;nucleoplasm;cytoplasm;autophagosome;Golgi apparatus;trans-Golgi network;cytosol;perinuclear region of cytoplasm;recycling endosome membrane
Molecular function
protein binding;protein C-terminus binding;Rab GTPase binding;protein binding, bridging;polyubiquitin modification-dependent protein binding;identical protein binding;metal ion binding;K63-linked polyubiquitin modification-dependent protein binding